Abstract
Macrolactins are secondary metabolites mainly from marine microorganisms bearing a unique 24-membered lactone core structure. Since their first occurrence in 1989, they have attracted considerable attention from natural product chemists, organic chemists, and pharmacologists due to their chemical complexity, potent antimicrobial and antitumor activities. Some of them are serving as lead compounds for drug discovery. Although a number of synthetic approaches have been developed, sample supply remains a big issue which precludes further investigation of pharmacological application and mechanisms of action. This review summarizes current knowledge about macrolactins including their chemical diversity, biological activities, synthetic studies, and efficient preparation.
Keywords: Antibiotic, antitumor, chemical diversity, efficient preparation, macrolactins, synthesis.
Current Organic Chemistry
Title:Macrolactins: Antitumor Antibiotics as Marine Drug Lead
Volume: 18 Issue: 7
Author(s): Tingting Wang, Shan He, Xiaojun Yan and Peng Zhu
Affiliation:
Keywords: Antibiotic, antitumor, chemical diversity, efficient preparation, macrolactins, synthesis.
Abstract: Macrolactins are secondary metabolites mainly from marine microorganisms bearing a unique 24-membered lactone core structure. Since their first occurrence in 1989, they have attracted considerable attention from natural product chemists, organic chemists, and pharmacologists due to their chemical complexity, potent antimicrobial and antitumor activities. Some of them are serving as lead compounds for drug discovery. Although a number of synthetic approaches have been developed, sample supply remains a big issue which precludes further investigation of pharmacological application and mechanisms of action. This review summarizes current knowledge about macrolactins including their chemical diversity, biological activities, synthetic studies, and efficient preparation.
Export Options
About this article
Cite this article as:
Wang Tingting, He Shan, Yan Xiaojun and Zhu Peng, Macrolactins: Antitumor Antibiotics as Marine Drug Lead, Current Organic Chemistry 2014; 18 (7) . https://dx.doi.org/10.2174/138527281807140515144549
DOI https://dx.doi.org/10.2174/138527281807140515144549 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Evaluation of Drug Transporter Interactions in Drug Discovery and Development
Combinatorial Chemistry & High Throughput Screening Doxorubicin vs. ladirubicin: methods for improving osteosarcoma treatment
Mini-Reviews in Medicinal Chemistry Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?
Current Cancer Drug Targets Potential Health Hazards for Cumulative Exposures to Phthalates and Ionizing Radiation in High-Risk Pediatric Population
Mini-Reviews in Medicinal Chemistry Animal Peptides Targeting Voltage-Activated Sodium Channels
Current Pharmaceutical Design Radiopharmaceutical Chemistry with Iodine-124: A Non-Standard Radiohalogen for Positron Emission Tomography
Medicinal Chemistry Vascular Endothelial Cell Growth Factor (VEGF), An Emerging Target for Cancer Chemotherapy
Current Medicinal Chemistry - Anti-Cancer Agents Recombinant Antibodies in Cancer Therapy
Current Protein & Peptide Science Therapeutic Strategies to Target TGF-β in the Treatment of Bone Metastases
Current Pharmaceutical Biotechnology The Urokinase Receptor and its Structural Homologue C4.4A in Human Cancer: Expression, Prognosis and Pharmacological Inhibition
Current Medicinal Chemistry VEGFA and PlGF Protein Signature of Primary Stage IV Rectal Cancer Pre and Post Neoadjuvant Radiotherapy, Bevacizumab, and Chemotherapy
Current Angiogenesis (Discontinued) Antineoplastic Potential of Medicinal Plants
Recent Patents on Biotechnology Molecular Targets in Cancer Drug Discovery: Cell-Based Profiling
Current Pharmaceutical Design Viral Mediated Gene Therapy for the Management of Metastatic Thyroid Carcinoma
Current Drug Targets - Immune, Endocrine & Metabolic Disorders MicroRNA: Biogenesis, Function and Role in Cancer
Current Genomics Transient Receptor Potential Channels and Dermatological Disorders
Current Topics in Medicinal Chemistry Structure-Function Relationships in the Interaction Between the Urokinase- Type Plasminogen Activator and Its Receptor
Current Pharmaceutical Design Mitochondrial genome sequencing in atherosclerosis: what's next?
Current Pharmaceutical Design